- Home
- TTNP vs PALI Comparison
TTNP vs PALI Comparison
Compare TTNP & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- PALI
- Stock Information
- Founded
- TTNP 1991
- PALI 1996
- Country
- TTNP United States
- PALI United States
- Employees
- TTNP N/A
- PALI N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TTNP Health Care
- PALI Health Care
- Exchange
- TTNP Nasdaq
- PALI Nasdaq
- Market Cap
- TTNP 3.0M
- PALI 3.4M
- IPO Year
- TTNP 1996
- PALI N/A
- Fundamental
- Price
- TTNP $3.67
- PALI $0.94
- Analyst Decision
- TTNP
- PALI Strong Buy
- Analyst Count
- TTNP 0
- PALI 2
- Target Price
- TTNP N/A
- PALI $23.00
- AVG Volume (30 Days)
- TTNP 25.0K
- PALI 192.2K
- Earning Date
- TTNP 03-31-2025
- PALI 03-25-2025
- Dividend Yield
- TTNP N/A
- PALI N/A
- EPS Growth
- TTNP N/A
- PALI N/A
- EPS
- TTNP N/A
- PALI N/A
- Revenue
- TTNP N/A
- PALI N/A
- Revenue This Year
- TTNP N/A
- PALI N/A
- Revenue Next Year
- TTNP N/A
- PALI N/A
- P/E Ratio
- TTNP N/A
- PALI N/A
- Revenue Growth
- TTNP N/A
- PALI N/A
- 52 Week Low
- TTNP $3.03
- PALI $0.89
- 52 Week High
- TTNP $14.80
- PALI $9.65
- Technical
- Relative Strength Index (RSI)
- TTNP 50.98
- PALI 24.22
- Support Level
- TTNP $3.35
- PALI $0.95
- Resistance Level
- TTNP $4.24
- PALI $1.08
- Average True Range (ATR)
- TTNP 0.29
- PALI 0.09
- MACD
- TTNP 0.02
- PALI -0.01
- Stochastic Oscillator
- TTNP 46.73
- PALI 10.43
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.